


Solar Grants Biotechnology Revenue
Biotechnology Research • London, Ontario, Canada • 1-10 Employees
Solar Grants Biotechnology revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Key Contact at Solar Grants Biotechnology
Igor Kolotilin
CSO & President
Company overview
| Headquarters | 401-140 Oxford St E, 401, London, Ontario N6A 5R9, CA |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Employees | 1-10 |
About Solar Grants Biotechnology
Solar Grants Biotechnology Inc., formerly known as Scattered Gold Biotechnology Inc (SGB Inc) is a young Canadian biotechnology company focused on harnessing the power of photosynthesis into the production of recombinant proteins. The company develops carefully crafted, state-of-the-art engineered tobacco plant lines that express and accumulate various recombinant proteins and peptides. The process of production is compellingly cost-effective, when compared with the conventional, fermenter bioreactor-based technologies. Developed by SGB Inc, the fine-tuned, photosynthetic “bioreactor tobacco plants” are capable of producing gram-amounts of recombinant proteins in one plant, while reducing carbon dioxide amount in the air and requiring minimal up-front investment - the characteristics of a remarkably environmentally-friendly, energy-efficient and cost-effective bioprocess!
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Solar Grants Biotechnology has never raised funding before.
Frequently asked questions
4.8
40,000 users



